Sassa S, Drummond G S, Bernstein S E, Kappas A
J Exp Med. 1985 Sep 1;162(3):864-76. doi: 10.1084/jem.162.3.864.
The effects of long-term administration of very large doses of Sn-protoporphyrin on hematological indices, histological changes, plasma bilirubin levels, tissue heme oxygenase activity, and activities of heme biosynthetic enzymes, were examined in genetically anemic mutant mice with hemolytic anemia (sphha/sphha). Long-term weekly treatment with Sn-protoporphyrin (100 mumol/kg body weight for 32 wk) did not alter hematological indices, histological findings, or enzyme activities related to heme biosynthesis, even though it resulted in sustained decreases in microsomal heme oxygenase activity in the liver, kidney, and spleen, and a prolonged decrease in plasma bilirubin concentration. Inhibition of heme oxygenase did not alter the level of cytochrome P-450 in the liver and the kidney. The results indicate that long-term treatment with massive doses of Sn-protoporphyrin suppresses bilirubin formation but does not produce significant histopathological changes or appreciably interfere with heme synthesis, in this strain of genetically anemic mice. These findings provide further support for the idea that suppression of heme degradation to bile pigment by the inhibition of heme oxygenase may prove useful to the prevention of severe hyperbilirubinemia in humans.
在患有溶血性贫血的遗传性贫血突变小鼠(sphha/sphha)中,研究了长期给予超大剂量锡原卟啉对血液学指标、组织学变化、血浆胆红素水平、组织血红素加氧酶活性以及血红素生物合成酶活性的影响。每周用锡原卟啉(100 μmol/kg体重,持续32周)进行长期治疗,尽管导致肝脏、肾脏和脾脏中的微粒体血红素加氧酶活性持续降低,以及血浆胆红素浓度长期下降,但并未改变血液学指标、组织学结果或与血红素生物合成相关的酶活性。血红素加氧酶的抑制并未改变肝脏和肾脏中细胞色素P-450的水平。结果表明,在这种遗传性贫血小鼠品系中,长期用大剂量锡原卟啉治疗可抑制胆红素形成,但不会产生明显的组织病理学变化或明显干扰血红素合成。这些发现进一步支持了这样一种观点,即通过抑制血红素加氧酶来抑制血红素降解为胆色素可能对预防人类严重高胆红素血症有用。